{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:00:12Z","timestamp":1762254012877,"version":"build-2065373602"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15019-6","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:52:30Z","timestamp":1762253550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma lipidomics for biomarker identification in non-muscle invasive bladder cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Yi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"1","key":"15019_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.euo.2020.09.001","volume":"4","author":"FJPV Valenberg","year":"2021","unstructured":"Valenberg FJPV, Hiar AM, Wallace E, et al. Validation of an mRNA-based urine test for the detection of bladder cancer in patients with haematuria. Eur Urol Oncol. 2021;4(1):93\u2013101.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"15019_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030709","volume":"15","author":"E Papavasiliou","year":"2023","unstructured":"Papavasiliou E, Sills VA, Calanzani N, et al. Diagnostic performance of biomarkers for bladder cancer detection suitable for community and primary care settings: a systematic review and meta-analysis. Cancers (Basel). 2023;15(3):709.","journal-title":"Cancers (Basel)"},{"key":"15019_CR3","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ajcn\/84.3.531","volume":"84","author":"MC Walsh","year":"2006","unstructured":"Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr. 2006;84:531\u20139.","journal-title":"Am J Clin Nutr"},{"key":"15019_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jchromb.2015.07.011","volume":"1000","author":"E C\u00edfkov\u00e1","year":"2015","unstructured":"C\u00edfkov\u00e1 E, Hol\u02c7capek M, L\u00edsa M, Vr\u00e1na D, Melichar B, \u0160tudent V. Lipidomic differentiation between human kidney tumors and surrounding normal tissues using HILIC-HPLC\/ESI-MS and multivariate data analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1000:14\u201321.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"15019_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0199-0","volume":"7","author":"F Yan","year":"2018","unstructured":"Yan F, Zhao H, Zeng Y. Lipidomics: a promising cancer biomarker. Clin Transl Med. 2018;7:21.","journal-title":"Clin Transl Med"},{"issue":"35","key":"15019_CR6","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1200\/JCO.2016.68.4837","volume":"34","author":"L Yang","year":"2016","unstructured":"Yang L, Drake BF, Colditz GA. Obesity and other cancers. J Clin Oncol. 2016;34(35):4231\u20137.","journal-title":"J Clin Oncol"},{"issue":"6","key":"15019_CR7","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.euf.2018.04.001","volume":"5","author":"R Campi","year":"2019","unstructured":"Campi R, Brookman-May SD, Subiela Henr\u00edquez JD, et al. Impact of metabolic diseases, drugs, and dietary factors on prostate cancer risk, recurrence, and survival: a systematic review by the European association of urology section of oncological urology. Eur Urol Focus. 2019;5(6):1029\u201357.","journal-title":"Eur Urol Focus"},{"issue":"7","key":"15019_CR8","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1021\/pr500409q","volume":"13","author":"X Zang","year":"2014","unstructured":"Zang X, Jones CM, Long TQ, et al. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics. J Proteome Res. 2014;13(7):3444\u201354.","journal-title":"J Proteome Res"},{"issue":"24","key":"15019_CR9","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1093\/bioinformatics\/btn506","volume":"24","author":"M Osl","year":"2008","unstructured":"Osl M, Dreiseitl S, Pfeifer B, et al. A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry. Bioinformatics. 2008;24(24):2908\u201314.","journal-title":"Bioinformatics"},{"issue":"3","key":"15019_CR10","doi-asserted-by":"publisher","first-page":"e88841","DOI":"10.1371\/journal.pone.0088841","volume":"9","author":"N Patel","year":"2014","unstructured":"Patel N, Vogel R, Chandra-Kuntal K, et al. A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer. PLoS ONE. 2014;9(3):e88841.","journal-title":"PLoS ONE"},{"issue":"1","key":"15019_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s11306-009-0187-x","volume":"6","author":"PG Lokhov","year":"2009","unstructured":"Lokhov PG, Dashtiev MI, Moshkovskii SA, et al. Metabolite profiling of blood plasma of patients with prostate cancer. Metabolomics. 2009;6(1):156\u201363. https:\/\/doi.org\/10.1007\/s11306-009-0187-x.","journal-title":"Metabolomics"},{"key":"15019_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00717","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Zhang M, Cheng X, Liu X, Sun H, Guo Z, et al. LC-MS-based plasma metabolomics and lipidomics analyses for differential diagnosis of bladder cancer and renal cell carcinoma. Front Oncol. 2020;10:717.","journal-title":"Front Oncol"},{"key":"15019_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1061083","volume":"13","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Sun W, Ji Z, et al. Serum metabolites as early detection markers of non-muscle invasive bladder cancer in Chinese patients. Front Oncol. 2023;13:1061083.","journal-title":"Front Oncol"},{"issue":"1","key":"15019_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ucl.2022.09.009","volume":"50","author":"Y Lotan","year":"2023","unstructured":"Lotan Y, Baky FJ. Urine-based markers for detection of urothelial cancer and for the management of non-muscle-invasive bladder cancer. Urol Clin North Am. 2023;50(1):53\u201367. https:\/\/doi.org\/10.1016\/j.ucl.2022.09.009.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"15019_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021652","volume":"24","author":"TC Hsu","year":"2023","unstructured":"Hsu TC, Rodrigues GOL, Winer H, et al. A focused review of Ras guanine nucleotide-releasing protein 1 in immune cells and cancer. Int J Mol Sci. 2023;24(2):1652.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"15019_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","volume":"20","author":"JA Olzmann","year":"2019","unstructured":"Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat Rev Mol Cell Biol. 2019;20(3):137\u201355.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"15019_CR17","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.molcel.2022.06.003","volume":"82","author":"J Zhou","year":"2022","unstructured":"Zhou J, Simon JM, Liao C, et al. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. Mol Cell. 2022;82(16):3030\u2013e30448.","journal-title":"Mol Cell"},{"issue":"1","key":"15019_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0003-9861(88)90195-6","volume":"262","author":"JT Hsieh","year":"1988","unstructured":"Hsieh JT, Verma AK. Involvement of protein kinase C in the transcriptional regulation of ornithine decarboxylase gene expression by 12-O-tetradecanoylphorbol-13-acetate in T24 human bladder carcinoma cells. Arch Biochem Biophys. 1988;262(1):326\u201336.","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"15019_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/ijc.10424","volume":"99","author":"K Lang","year":"2002","unstructured":"Lang K, Niggemann B, Zanker KS, et al. Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loop. Int J Cancer. 2002;99(5):673\u201380.","journal-title":"Int J Cancer"},{"key":"15019_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00012","volume":"8","author":"LT Tan","year":"2017","unstructured":"Tan LT, Chan KG, Pusparajah P, et al. Targeting membrane lipid a potential cancer cure?? Front Pharmacol. 2017;8:12.","journal-title":"Front Pharmacol"},{"issue":"6","key":"15019_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/metabo12060544","volume":"12","author":"KR Kami Reddy","year":"2022","unstructured":"Kami Reddy KR, Piyarathna DWB, Kamal AHM, et al. Lipidomic profiling identifies a novel lipid signature associated with ethnicity-specific disparity of bladder cancer. Metabolites. 2022;12(6):544.","journal-title":"Metabolites"},{"issue":"6","key":"15019_CR22","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.euf.2017.04.005","volume":"4","author":"DWB Piyarathna","year":"2018","unstructured":"Piyarathna DWB, Rajendiran TM, Putluri V, et al. Distinct lipidomic landscapes associated with clinical stages of urothelial cancer of the bladder. Eur Urol Focus. 2018;4(6):907\u201315. https:\/\/doi.org\/10.1016\/j.euf.2017.04.005.","journal-title":"Eur Urol Focus"},{"key":"15019_CR23","doi-asserted-by":"publisher","unstructured":"Ryan MJ, Grant-St James A, Lawler NG, Fear MW, Raby E, Wood FM, et al. Comprehensive Lipidomic Workflow for Multicohort Population Phenotyping Using Stable Isotope Dilution Targeted Liquid Chromatography-Mass Spectrometry. J Proteome Res. 2023;22(5):1419-1433. https:\/\/doi.org\/10.1021\/acs.jproteome.","DOI":"10.1021\/acs.jproteome"},{"issue":"1","key":"15019_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12967-024-05446-7","volume":"22","author":"C Wu","year":"2024","unstructured":"Wu C, Wei X, Huang Z, et al. Urinary microbiome dysbiosis is associated with an inflammatory environment and perturbed fatty acids metabolism in the pathogenesis of bladder cancer. J Transl Med. 2024;22(1):628. https:\/\/doi.org\/10.1186\/s12967-024-05446-7.","journal-title":"J Transl Med"},{"issue":"4","key":"15019_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3349\/ymj.2016.57.4.865","volume":"57","author":"WT Kim","year":"2016","unstructured":"Kim WT, Yun SJ, Yan C, et al. Metabolic pathway signatures associated with urinary metabolite biomarkers differentiate bladder cancer patients from healthy controls. Yonsei Med J. 2016;57(4):865\u201371. https:\/\/doi.org\/10.3349\/ymj.2016.57.4.865.","journal-title":"Yonsei Med J"},{"key":"15019_CR26","doi-asserted-by":"crossref","unstructured":"Ma J, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47(D1):D1211\u2013D1217.","DOI":"10.1093\/nar\/gky869"},{"key":"15019_CR27","doi-asserted-by":"crossref","unstructured":"Chen T, et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 2021;50(D1):D1522\u2013D1527.","DOI":"10.1093\/nar\/gkab1081"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15019-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:52:35Z","timestamp":1762253555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15019-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15019"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15019-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Review Committee of the Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Sciences, Peking Union Medical College (2022120), and written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1702"}}